Tonix Pharmaceuticals To Present Effects Of TONMYA On Fibromyalgia Symptoms And Physical Function At The World Congress On Pain, October 26-30

Benzinga · 2d ago

TONMYA was approved by the U.S. Food and Drug Administration on August 15, 2025, and commercially launched in the U.S. on November 17, 2025.

Poster Presentation Details

Title: Cyclobenzaprine HCl Sublingual Reduces Fibromyalgia Impact on Physical Symptoms & Functional Ability

Poster #: 157

Poster Session: 2

Date: October 27, 2026

Time: 3:15-4:45 p.m. ICT

Presenter: Errol Gould, Ph.D., Senior Vice President, Medical Affairs, Tonix Medicines